Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication January 23, 2019
- Accepted for publication January 24, 2019
- Published online March 1, 2019.
Article Versions
- previous version (February 7, 2019 - 09:19).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2019 by the Society of Nuclear Medicine and Molecular Imaging.
Author Information
- Ramsey D. Badawi1,2,
- Hongcheng Shi3,
- Pengcheng Hu3,
- Shuguang Chen3,
- Tianyi Xu4,
- Patricia M. Price5,
- Yu Ding4,
- Benjamin A. Spencer1,
- Lorenzo Nardo1,
- Weiping Liu4,
- Jun Bao4,
- Terry Jones1,
- Hongdi Li4 and
- Simon R. Cherry1,2
- 1Department of Radiology, University of California Davis Medical Center, Sacramento, California
- 2Department of Biomedical Engineering, University of California, Davis, California
- 3Department of Nuclear Medicine, Zhongshan Hospital Fudan University, Shanghai, China
- 4United Imaging Healthcare, Shanghai, China; and
- 5Department of Surgery and Cancer, Imperial College, London, United Kingdom
- For correspondence or reprints contact either of the following:Ramsey D. Badawi, Department of Radiology, UC Davis School of Medicine, 4860 Y St., Sacramento, CA 95817. E-mail: rdbadawi{at}ucdavis.edu
- Hongcheng Shi, Department of Nuclear Medicine, Zhongshan Hospital Fudan University, 180 Fenglin Rd., Xuhui District, Shanghai, China. E-mail: shi.hongcheng{at}zs-hospital.sh.cn
Cited By...
Article usage
First Human Imaging Studies with the EXPLORER Total-Body PET Scanner*
Jump to section
Related Articles
Cited By...
- A blueprint for translational regenerative medicine
- The Future of Nuclear Medicine, Molecular Imaging, and Theranostics
- Benefit of Improved Performance with State-of-the Art Digital PET/CT for Lesion Detection in Oncology
- High-Resolution Depth-Encoding PET Detector Module with Prismatoid Light-Guide Array
- The Changing Face of Nuclear Cardiology: Guiding Cardiovascular Care Toward Molecular Medicine
- Fifty Years of Radiopharmaceuticals
- The Potential of PET in the Management of Peripheral Arterial Disease
- Total-Body PET and Highly Stable Chelators Together Enable Meaningful 89Zr-Antibody PET Studies up to 30 Days After Injection
- Total-Body PET Imaging for up to 30 Days After Injection of 89Zr-Labeled Antibodies
- Brief Report: Subsecond total-body imaging using ultrasensitive positron emission tomography
- Total-Body Dynamic Reconstruction and Parametric Imaging on the uEXPLORER
- PennPET Explorer: Human Imaging on a Whole-Body Imager
- PennPET Explorer: Design and Preliminary Performance of a Whole-Body Imager
- CellGPS: Whole-body tracking of single cells by positron emission tomography